Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Attitude Small Stock Discussion -- Ignore unavailable to you. Want to Upgrade?

To: David Graham who wrote (266)	11/18/1997 2:58:00 PM
From: majormember	Read Replies (1) \| Respond to of 385

As for FDA approval, Sunrise Technologies, SNRS has a YAG Holmium corneal shaping laser in the works that has a greater market potential than the current excimer lasers produced by VISX & Summit. Red Chip Review gives them a "B" rating and says Co. is better managed and has superior "non-invasive" far-sightedness correction. Current CEO is ex-Algan Sr.V.P. responsible for many FDA approvals. Currently sells at 3 3/4. Assuming FDA approval, valuation could go to the moon; (what would the valuation be for going into Dr. wearing glasses, and walking out, without cutting eye tissue as w/ LASIK? If anyones interested check out: ifw.com Co. home page: sunrise-tech.com Skane